Company
Phlox Therapeutics
- Biotech
- Headquarters:
- Naarden
Description
Phlox Therapeutics develops precision RNA-based therapies to treat rare genetic cardiomyopathies, producing therapeutic RNA molecules and collaborating with partners to deliver them to the heart for patient care.
Related
Atomic AIAtomic AI develops machine-learning and structural-biology tools for RNA drug discovery, supporting RNA-targeted small molecules, RNA-based…
Krystal Biotech ($KRYS)Krystal Biotech develops and commercializes redosable gene therapies to treat severe, life‑threatening, or rare diseases by correcting…
Ionis Pharmaceuticals ($IONS)Ionis Pharmaceuticals develops RNA- and DNA-targeted therapeutics, designing antisense and related nucleic acid medicines to treat serious…
Beam Therapeutics ($BEAM)Beam Therapeutics develops precision genetic medicines using base editing and delivery technologies to create investigational therapies for…
4BIO Capital4BIO Capital invests in and supports early-stage companies developing advanced therapies, including cell and gene, RNA-based, targeted…
FIRE1FIRE1 builds heart-failure care tools for restoring patients' everyday health and function; used by clinicians and patients managing heart…
Intelligent TherapeuticsIntelligent Therapeutics engineers novel antibodies and antibody-like molecules for treating solid tumors and rare autoimmune diseases,…
Relay Therapeutics ($RLAY)Relay Therapeutics develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously…
Fred Hutchinson Cancer CenterFred Hutchinson Cancer Center conducts biomedical research and provides cancer patient care, offering prevention, early-detection, genetic…
Intellia Therapeutics ($NTLA)Intellia Therapeutics develops CRISPR-based gene editing medicines, creating therapeutic candidates intended to cure severe genetic and…
Medical University of South CarolinaMedical University of South Carolina educates health professionals, conducts biomedical and clinical research, and delivers patient care…
ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…